Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1649]
News [6505]
Articles [99]
Editorials [4]
Conferences [186]
elearning [21]
De-activating chromosomes to prevent cancer
Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy
De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )
21 Jul 2015
From stem cell to cancer stem cell
Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy
From stem cell to cancer stem cell ( Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy )
21 Jul 2015
From innovation to improved patient care: challenges for foundations and cancer...
Dr Jacques Raynaud - Association pour la recherche sur le cancer (ARC)...
From innovation to improved patient care: challenges for foundations and cancer research organisations ( Dr Jacques Raynaud - Association pour la recherche sur le cancer (ARC), Villejuif, France )
6 Jul 2015
The importance of target expression in personalised medicine
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
The importance of target expression in personalised medicine ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015
Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast
Prof Bin Tean Teh - National Singapore Cancer Center, Singapore
Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast ( Prof Bin Tean Teh - National Singapore Cancer Center, Singapore )
3 Jul 2015
Chemoresistance and residual disease promoted by DNMT3A R882 in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015
Exploring "bad luck" - why do some patients develop myeloid leukaemia?
Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK
Exploring "bad luck" - why do some patients develop myeloid leukaemia? ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )
13 Jun 2015
Genomic sequencing to find AML-causing mutations
Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK
Genomic sequencing to find AML-causing mutations ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )
13 Jun 2015
DNMT3A R882 mutations promote chemoresistance and residual disease in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
12 Jun 2015
ecancermedicalscience editor's choice for May 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for May 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
26 May 2015
WIN 2015: Oncologists and industry working together for personalised medicine
Prof Razelle Kurzrock - University of California, San Diego, USA
WIN 2015: Oncologists and industry working together for personalised medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )
13 May 2015
Certain classes of genes in patients that could lead to prostate cancer
Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA
Certain classes of genes in patients that could lead to prostate cancer ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )
1 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation